Cargando…
Metalloproteinases 1 and 3 as Potential Biomarkers in Breast Cancer Development
Breast cancer continues to be one of the main causes of morbidity and mortality globally and was the leading cause of cancer death in women in Spain in 2020. Early diagnosis is one of the most effective methods to lower the incidence and mortality rates of breast cancer. The human metalloproteinases...
Autores principales: | Argote Camacho, Angela Ximena, González Ramírez, Amanda Rocío, Pérez Alonso, Alejandro José, Rejón García, Juan David, Olivares Urbano, María Auxiliadora, Torné Poyatos, Pablo, Ríos Arrabal, Sandra, Núñez, María Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396449/ https://www.ncbi.nlm.nih.gov/pubmed/34445715 http://dx.doi.org/10.3390/ijms22169012 |
Ejemplares similares
-
Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study
por: Olivares‐Urbano, María Auxiliadora, et al.
Publicado: (2019) -
Radiation and Stemness Phenotype May Influence Individual Breast Cancer Outcomes: The Crucial Role of MMPs and Microenvironment
por: Olivares-Urbano, María Auxiliadora, et al.
Publicado: (2019) -
CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
por: Olivares-Urbano, María Auxiliadora, et al.
Publicado: (2020) -
miRNAs as radio‐response biomarkers for breast cancer stem cells
por: Griñán‐Lisón, Carmen, et al.
Publicado: (2020) -
Involvement of free radicals in breast cancer
por: Ríos-Arrabal, Sandra, et al.
Publicado: (2013)